These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24769718)

  • 1. ACVR1 mutations and the genomic landscape of pediatric diffuse glioma.
    Zadeh G; Aldape K
    Nat Genet; 2014 May; 46(5):421-2. PubMed ID: 24769718
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetics: ACVR1 mutations-a key piece in paediatric diffuse glioma.
    Villanueva MT
    Nat Rev Clin Oncol; 2014 Jun; 11(6):300. PubMed ID: 24840074
    [No Abstract]   [Full Text] [Related]  

  • 3. Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma.
    Taylor KR; Mackay A; Truffaux N; Butterfield Y; Morozova O; Philippe C; Castel D; Grasso CS; Vinci M; Carvalho D; Carcaboso AM; de Torres C; Cruz O; Mora J; Entz-Werle N; Ingram WJ; Monje M; Hargrave D; Bullock AN; Puget S; Yip S; Jones C; Grill J
    Nat Genet; 2014 May; 46(5):457-461. PubMed ID: 24705252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACVR1 R206H cooperates with H3.1K27M in promoting diffuse intrinsic pontine glioma pathogenesis.
    Hoeman CM; Cordero FJ; Hu G; Misuraca K; Romero MM; Cardona HJ; Nazarian J; Hashizume R; McLendon R; Yu P; Procissi D; Gadd S; Becher OJ
    Nat Commun; 2019 Mar; 10(1):1023. PubMed ID: 30833574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations.
    Buczkowicz P; Hoeman C; Rakopoulos P; Pajovic S; Letourneau L; Dzamba M; Morrison A; Lewis P; Bouffet E; Bartels U; Zuccaro J; Agnihotri S; Ryall S; Barszczyk M; Chornenkyy Y; Bourgey M; Bourque G; Montpetit A; Cordero F; Castelo-Branco P; Mangerel J; Tabori U; Ho KC; Huang A; Taylor KR; Mackay A; Bendel AE; Nazarian J; Fangusaro JR; Karajannis MA; Zagzag D; Foreman NK; Donson A; Hegert JV; Smith A; Chan J; Lafay-Cousin L; Dunn S; Hukin J; Dunham C; Scheinemann K; Michaud J; Zelcer S; Ramsay D; Cain J; Brennan C; Souweidane MM; Jones C; Allis CD; Brudno M; Becher O; Hawkins C
    Nat Genet; 2014 May; 46(5):451-6. PubMed ID: 24705254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma.
    Fontebasso AM; Papillon-Cavanagh S; Schwartzentruber J; Nikbakht H; Gerges N; Fiset PO; Bechet D; Faury D; De Jay N; Ramkissoon LA; Corcoran A; Jones DT; Sturm D; Johann P; Tomita T; Goldman S; Nagib M; Bendel A; Goumnerova L; Bowers DC; Leonard JR; Rubin JB; Alden T; Browd S; Geyer JR; Leary S; Jallo G; Cohen K; Gupta N; Prados MD; Carret AS; Ellezam B; Crevier L; Klekner A; Bognar L; Hauser P; Garami M; Myseros J; Dong Z; Siegel PM; Malkin H; Ligon AH; Albrecht S; Pfister SM; Ligon KL; Majewski J; Jabado N; Kieran MW
    Nat Genet; 2014 May; 46(5):462-6. PubMed ID: 24705250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACVR1 mutations in DIPG: lessons learned from FOP.
    Taylor KR; Vinci M; Bullock AN; Jones C
    Cancer Res; 2014 Sep; 74(17):4565-70. PubMed ID: 25136070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma.
    Wu G; Diaz AK; Paugh BS; Rankin SL; Ju B; Li Y; Zhu X; Qu C; Chen X; Zhang J; Easton J; Edmonson M; Ma X; Lu C; Nagahawatte P; Hedlund E; Rusch M; Pounds S; Lin T; Onar-Thomas A; Huether R; Kriwacki R; Parker M; Gupta P; Becksfort J; Wei L; Mulder HL; Boggs K; Vadodaria B; Yergeau D; Russell JC; Ochoa K; Fulton RS; Fulton LL; Jones C; Boop FA; Broniscer A; Wetmore C; Gajjar A; Ding L; Mardis ER; Wilson RK; Taylor MR; Downing JR; Ellison DW; Zhang J; Baker SJ
    Nat Genet; 2014 May; 46(5):444-450. PubMed ID: 24705251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shared ACVR1 mutations in FOP and DIPG: Opportunities and challenges in extending biological and clinical implications across rare diseases.
    Han HJ; Jain P; Resnick AC
    Bone; 2018 Apr; 109():91-100. PubMed ID: 28780023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential kinase activity of ACVR1 G328V and R206H mutations with implications to possible TβRI cross-talk in diffuse intrinsic pontine glioma.
    Cao H; Jin M; Gao M; Zhou H; Tao YJ; Skolnick J
    Sci Rep; 2020 Apr; 10(1):6140. PubMed ID: 32273545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma.
    Nikbakht H; Panditharatna E; Mikael LG; Li R; Gayden T; Osmond M; Ho CY; Kambhampati M; Hwang EI; Faury D; Siu A; Papillon-Cavanagh S; Bechet D; Ligon KL; Ellezam B; Ingram WJ; Stinson C; Moore AS; Warren KE; Karamchandani J; Packer RJ; Jabado N; Majewski J; Nazarian J
    Nat Commun; 2016 Apr; 7():11185. PubMed ID: 27048880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shared mutation for two childhood diseases.
    Delude CM
    J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 25006195
    [No Abstract]   [Full Text] [Related]  

  • 13. Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma.
    Jones C; Baker SJ
    Nat Rev Cancer; 2014 Oct; 14(10):. PubMed ID: 25230881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant ACVR1 Arrests Glial Cell Differentiation to Drive Tumorigenesis in Pediatric Gliomas.
    Fortin J; Tian R; Zarrabi I; Hill G; Williams E; Sanchez-Duffhues G; Thorikay M; Ramachandran P; Siddaway R; Wong JF; Wu A; Apuzzo LN; Haight J; You-Ten A; Snow BE; Wakeham A; Goldhamer DJ; Schramek D; Bullock AN; Dijke PT; Hawkins C; Mak TW
    Cancer Cell; 2020 Mar; 37(3):308-323.e12. PubMed ID: 32142668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common mutations in ALK2/ACVR1, a multi-faceted receptor, have roles in distinct pediatric musculoskeletal and neural orphan disorders.
    Pacifici M; Shore EM
    Cytokine Growth Factor Rev; 2016 Feb; 27():93-104. PubMed ID: 26776312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent perspectives of molecular aberrations in pediatric high-grade glioma.
    Li Z; Sun Q; Shi Y
    Minerva Pediatr; 2020 Apr; 72(2):116-122. PubMed ID: 28643992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of FKBP12 and type II BMP receptors on signal transduction by ALK2 activating mutations associated with genetic disorders.
    Machiya A; Tsukamoto S; Ohte S; Kuratani M; Fujimoto M; Kumagai K; Osawa K; Suda N; Bullock AN; Katagiri T
    Bone; 2018 Jun; 111():101-108. PubMed ID: 29551750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal Transduction in Diffuse Intrinsic Pontine Glioma.
    Duchatel RJ; Jackson ER; Alvaro F; Nixon B; Hondermarck H; Dun MD
    Proteomics; 2019 Nov; 19(21-22):e1800479. PubMed ID: 31328874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas.
    Wu G; Broniscer A; McEachron TA; Lu C; Paugh BS; Becksfort J; Qu C; Ding L; Huether R; Parker M; Zhang J; Gajjar A; Dyer MA; Mullighan CG; Gilbertson RJ; Mardis ER; Wilson RK; Downing JR; Ellison DW; Zhang J; Baker SJ;
    Nat Genet; 2012 Jan; 44(3):251-3. PubMed ID: 22286216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics.
    Hoffman LM; DeWire M; Ryall S; Buczkowicz P; Leach J; Miles L; Ramani A; Brudno M; Kumar SS; Drissi R; Dexheimer P; Salloum R; Chow L; Hummel T; Stevenson C; Lu QR; Jones B; Witte D; Aronow B; Hawkins CE; Fouladi M
    Acta Neuropathol Commun; 2016 Jan; 4():1. PubMed ID: 26727948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.